Literature DB >> 29179906

Diagnostic challenges in papillary lesions of the breast.

Emad A Rakha1, Ian O Ellis2.   

Abstract

Papillary lesions of the breast comprise a heterogeneous group of diseases ranging from benign and atypical lesions to malignant tumours including non-invasive and invasive entities. Although diagnosis of papillary lesions featuring typical histological features is straightforward, a proportion shows overlapping features, posing diagnostic challenges. In addition to being uncommon, the excellent behaviour of papillary tumours reduces the distinguishing value of individual histological features and increases the subjectivity of interpretation of various diagnostic features. Therefore the overall categorisation, which is based on a constellation of subjective features, may vary with subsequent management implications. Concordance studies revealed that recognition of papillary carcinomas (PC) as a malignant entity by pathologists is high, but concordance of its classification into in situ and invasive disease can be problematic, as can assessment of prognostic and predictive factors in the invasive component. Identification of low nuclear grade atypia within benign papillary lesions and its classification into atypia or in situ carcinoma may also pose a diagnostic challenge. Although immunohistochemistry is helpful in evaluation of benign and atypical lesions it has a limited utility in differentiating the majority of PC as non-invasive or invasive disease. Pathologists should be aware of the various entities and the differential diagnosis of each entity, the existence of lesions with overlapping features and should follow the updated guideline recommendation for their diagnosis and management. These rare lesions usually require additional diagnostic work-up and difficult cases should trigger consensus opinion or expert referral.
Copyright © 2017 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; challenges; diagnosis; papillary lesions

Mesh:

Year:  2017        PMID: 29179906     DOI: 10.1016/j.pathol.2017.10.005

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

1.  The Clinicopathologic Features of 22 Cases With Primary Invasive Papillary Carcinoma of the Breast Identified in 1153 Cases With Invasive Breast Carcinoma: Single-Center Experience.

Authors:  Canan Kelten Talu; Begum Yeni Erdem; Esra Arslan; Mehmet Ali Nazli; Yasemin Cakir; Didem Can Trabulus
Journal:  Eur J Breast Health       Date:  2022-10-01

2.  A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real-world experience.

Authors:  Xiaona Li; Huan Wang; Zhe Sun; Chuifeng Fan; Feng Jin; Xiaoyun Mao
Journal:  Cancer Med       Date:  2020-08-21       Impact factor: 4.452

Review 3.  Solid papillary carcinoma of the breast.

Authors:  Toyaja Jadhav; Shashi Shekhar Prasad; Bhupesh Guleria; Manvir Singh Tevatia; Prerna Guleria
Journal:  Autops Case Rep       Date:  2022-01-13

Review 4.  Papillary lesions of the breast.

Authors:  Janina Kulka; Lilla Madaras; Giuseppe Floris; Sigurd F Lax
Journal:  Virchows Arch       Date:  2021-11-03       Impact factor: 4.535

5.  How Accurately FNAC Reflects the Breast Papillary Lesions?

Authors:  Gülistan Gümrükçü; Meryem Doğan; Nilüfer Gürsan; Barış Boylu; Erhan Ekren; Fügen Vardar Aker
Journal:  J Cytol       Date:  2022-02-17       Impact factor: 1.000

Review 6.  Rare epithelial breast cancer: surgery and adjuvant therapy.

Authors:  Aida Abdelwahed; Muneer Ahmed
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

7.  Rare Papillary Breast Carcinoma Incidentally Discovered After Trauma-Induced Hematoma.

Authors:  Becky Li; Jackie Nguyen; Caitlin A Williams; Karina Cardenas; Ihor Pidhorecky
Journal:  Cureus       Date:  2021-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.